# EPU1 – Tunisia’s HealthTech Investments (FMM × HCI)

> Source: https://healthcareinnovation.tn/epu1-tunisias-healthtech-investments-fmm-x-hci/
> Author: healthcareinnovation.com
> Published: 2023-12-15
> Updated: 2026-09-23

What does it take to finance early-stage HealthTech in Tunisia? The morning panel hosted by the [Faculty of Medicine of Monastir (FMM)](https://www.fmm.rnu.tn/) and [HealthCare Innovation (HCI)](https://healthcareinnovation.tn/) explored the investment landscape for startups and charted realistic paths from idea to market. This article distills that discussion into practical steps—covering financing types, common bottlenecks, and high-impact levers founders can use to improve survival and scale-up.

## **Context & Audience**

 The session gathered 160 participants, including assistants and professors from university hospitals across Monastir, Sousse, Mahdia, and Tunis, as well as students in medicine, pharmacy, and computer science.

### **Why Funding HealthTech is Hard—and What to Do**

 Bank lending alone rarely fits innovative ventures; alternative instruments are crucial. According to the [OECD’s digital health analyses](https://www.oecd.org/health/digital-health.htm), scale-up frictions are common, and the [WHO Global Strategy on Digital Health](https://www.who.int/publications/i/item/9789240068891) highlights governance and workforce capacity as key enablers. https://www.youtube.com/watch?v=sF9K8mzeZh8&t=3107s

#### **Financing Types: Traditional & Alternative**

- Bootstrapping & Pre-sales — Extend runway with customer validation and early revenues.
- Incubators & Seed Funds — Access mentoring and small tickets to reach prototype maturity.
- Crowdfunding — Build a community of early adopters while raising capital; timelines typically range 3–4 months.
- Business Angels (BA) — Sector-savvy investors who bring expertise, lab access, and networks.
- Venture Capital & Private Equity — Increasing specialization; fit improves as traction and validation grow.

#### **Obstacles Slowing Valorization & Scale**

- Data governance barriers (GDPR-like constraints, sovereign cloud requirements).
- Insurance alignment lagging behind digital health innovation.
- Funding gaps between prototype and market, despite national startup funds.
- Limited late-early stage financing, pushing scale-ups to expand abroad.

#### **Levers to Improve Startup Survival**

- Assemble a strong founding team and advisers; document governance and track record.
- Publish research with clinicians to validate innovation and signal credibility.
- Focus on clear business models, market sizing, and a realistic path to revenues.
- Build access to rare expertise (clinical, regulatory, data) and formalize it in agreements.
- Use portfolio logic for investors: diversification, risk management, impact, and tax advantages.

#### **Practical Guidance for Founders**

- The best fundraising strategy can be not to fundraise: bootstrap, pre-sell, and retain strategic equity.
- Structure validation cycles to shorten time-to-proof; use hospital collaborations and lab testing.
- Map a stepwise financing path: own funds → incubation/seed → specialized funds as traction grows.

#### **What Early Investors Look For**

- Team quality, clarity of roles, and governance.
- Evidence of need–solution fit and early customer validation.
- Quality of innovation and defensibility.
- Transparent documentation and milestones tied to validation gates.

#### **HCI Resources**

 [Accelerating Innovation in HealthTech](https://healthcareinnovation.tn/accelerating-innovation-in-healthtech/) [Startup Programs](https://healthcareinnovation.tn/service/startups/) [Pharma & Medical Device Regulatory Services](https://healthcareinnovation.tn/service/pharma-medical-device/) [Experts Network](https://healthcareinnovation.tn/experts/) [Community Overview](https://healthcareinnovation.tn/community/)

#### **External Citations**

 [OECD](https://www.oecd.org/health/digital-health.htm) — Digital Health Overview WHO — [Global Strategy on Digital Health](https://www.who.int/publications/i/item/9789240068891) (2020–2025)

#### **FAQ**

 Q: What are realistic funding routes for a HealthTech startup in Tunisia? A: Start with bootstrapping and pre-sales, add incubation/seed, and engage Business Angels; prepare to access specialized funds after clinical validation. Q: Why do many startups expand abroad at later stages? A: Local late-early financing is limited; scaling often requires larger tickets and policy alignment available in other markets. Q: How can founders de-risk early? A: Co-design pilots with hospitals and research labs, publish results with clinicians, and document milestones tied to validation. Q: Where can I get support? A: Engage with [HCI’s Startup Programs](https://healthcareinnovation.tn/service/startups/), the [HCI Experts Network](https://healthcareinnovation.tn/experts/), and [HCI Regulatory Services](https://healthcareinnovation.tn/service/pharma-medical-device/).

## Frequently asked questions

### What are realistic funding routes for a HealthTech startup in Tunisia?

Start with bootstrapping and pre-sales, add incubation/seed, and engage Business Angels; prepare to access specialized funds after clinical validation.

### Where can I get support?

Engage with HCI’s Startup Programs, the HCI Experts Network, and HCI Regulatory Services.

### How can founders de-risk early?

Co-design pilots with hospitals and research labs, publish results with clinicians, and document milestones tied to validation.

### Why do many startups expand abroad at later stages?

Local late-early financing is limited; scaling often requires larger tickets and policy alignment available in other markets.